Hot Paths

Boston Scientific hit with cardiac device recall (BSX:NYSE)

Boston Scientific Offers To Buy Guidant For $25 Billion

Joe Raedle/Getty Images News

Boston Scientific (BSX) traded lower on Wednesday amid concerns over a widespread cybersecurity incident affecting its global operations and a product recall involving certain percutaneous catheters manufactured by the company.

The cardiac device maker fell ~5% in the morning trading after announcing

Exit mobile version